Read more

April 19, 2022
3 min watch
Save

VIDEO: Trudhesa nasal spray effective in treating migraines

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SEATTLE — Trudhesa was effective in treating migraines of varying severity, a speaker said at the 2022 American Academy of Neurology annual meeting.

Trudhesa (dihydroergotamine mesylate, Impel NeuroPharma)] worked when patients took it for their migraine attacks, even when their migraine attacks were severe,” Sheena K. Aurora, MD, a neurologist and vice president of medical affairs at Impel NeuroPharma, said.

Editor's Note: This article was revised on April 20, 2022, in order to better accurately describe the affects of Trudhesa.